Skip to Content
Global News Select

Kimberly-Clark 1Q Sales, Earnings Lower Compared With Pandemic's Early Days

By Matt Grossman


Kimberly-Clark Corp. Friday posted lower revenue and profit figures in the latest quarter as volumes retreated compared with an intense period of consumer stocking-up a year ago during the onset of the Covid-19 pandemic.

The Irving, Texas-based producer of paper and fiber products logged first-quarter earnings of $1.72 a share, a decline from $1.92 a share in the same three-month period a year earlier. Net income attributable to the company was $584 million, compared with $660 million in last year's first quarter.

Kimberly-Clark's adjusted earnings were $1.80 a share. Analysts surveyed by FactSet had forecast adjusted earnings of $1.93 a share.

Revenue was down 5% at $4.74 billion, compared with $5.01 billion a year ago. Analysts were expecting revenue of $4.98 billion.

Chairman and Chief Executive Mike Hsu attributed the declining performance to an imposing year-over-year comparison, because results from 2020's first quarter were boosted by stocking-up behavior as the coronavirus pandemic arrived in the U.S.

He added that severe winter weather in the South had caused temporary supply-chain disruptions earlier this year. The weather had caused the temporary shutdown of some manufacturing facilities and affected the availability of materials from suppliers.

Volumes were down by 10% in the quarter, compared with an increase of more than 8% in 2020's first quarter. Sales in the consumer-tissue segment fell 12% to $1.5 billion, while revenue from the company's K-C Professional business declined to $752 million, from $848 million a year earlier. Personal-care sales rose 2% to $2.46 billion, driven by expansion overseas.

The company's profitability was also dented by higher input costs for pulp and other materials, Kimberly-Clark said.


Write to Matt Grossman at


(END) Dow Jones Newswires

April 23, 2021 08:05 ET (12:05 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.